BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16326097)

  • 1. Borderline tumours of the ovary and fertility.
    Morice P
    Eur J Cancer; 2006 Jan; 42(2):149-58. PubMed ID: 16326097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
    Marcickiewicz J; Brännström M
    Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of fertility preserving operations in malignant ovarian tumors].
    Kleine W
    Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: case report.
    Attar E; Berkman S; Topuz S; Baysal B; Akhan S; Chambers JT
    Hum Reprod; 2004 Jun; 19(6):1472-5. PubMed ID: 15105388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study.
    Palomba S; Zupi E; Russo T; Falbo A; Del Negro S; Manguso F; Marconi D; Tolino A; Zullo F
    Hum Reprod; 2007 Feb; 22(2):578-85. PubMed ID: 17050549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conservative management of malignant and borderline ovarian tumor].
    Morice P; Camatte S; Wickart-Poque F; Rouzier R; Pautier P; Pomel C; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
    Bull Cancer; 2002 Dec; 89(12):1019-26. PubMed ID: 12525360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors.
    Yinon Y; Beiner ME; Gotlieb WH; Korach Y; Perri T; Ben-Baruch G
    Fertil Steril; 2007 Aug; 88(2):479-84. PubMed ID: 17408624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
    Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
    Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Borderline tumors of the ovary].
    Tropé CG; Baekelandt M; Bjørge T; Abeler V; Kaern J
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2764-70. PubMed ID: 11107921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer.
    Borgfeldt C; Iosif C; Måsbäck A
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):110-4. PubMed ID: 16859821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative surgery for borderline ovarian tumors: a review.
    Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
    Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Borderline tumors of the ovary: a multicenter study in 137 patients].
    Bonnamy L; Fignon A; Fetissof F; Berger C; Body G; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):272-81. PubMed ID: 11398004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of borderline ovarian neoplasms.
    Cadron I; Leunen K; Van Gorp T; Amant F; Neven P; Vergote I
    J Clin Oncol; 2007 Jul; 25(20):2928-37. PubMed ID: 17617524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assisted reproductive technologies after conservative management of borderline or invasive ovarian tumours].
    Fortin A; Hazout A; Thoury A; Alvès K; Bats AS; Dhainaut C; Madelenat P
    Gynecol Obstet Fertil; 2005; 33(7-8):488-97. PubMed ID: 16019249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of prognostic factors of malignant ovarian tumor after fertility-preserving treatment].
    Zeng DY; Shen K; Huang HF; Wu M; Pan LY; Yang JX; Lang JH
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2562-5. PubMed ID: 16321304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors and treatment for advanced-stage borderline ovarian tumors].
    Morice P; Camatte S; Rouzier R; Pautier P; Atallah D; Pomel C; Lhomme C; Duvillard P; Castaigne D
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7):623-8. PubMed ID: 12457134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.